These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4006263)

  • 1. The effect of topical phenylpropanolamine on nasal secretion and nasal airway resistance after histamine challenge in man.
    Löth S; Bende M
    Clin Otolaryngol Allied Sci; 1985 Feb; 10(1):15-9. PubMed ID: 4006263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathomimetics in nasal allergy.
    Bende M; Laurin L
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(4):238-42. PubMed ID: 3523369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine.
    Bende M; Andersson KE; Johansson CJ; Sjögren C; Svensson G
    Acta Otolaryngol; 1984; 98(5-6):543-7. PubMed ID: 6084394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis.
    Birchall MA; Henderson JC; Studham JM; Pride NB; Fuller RW
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):521-5. PubMed ID: 7895384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of terfenadine on unilateral nasal challenge with allergen.
    Wagenmann M; Baroody FM; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1994 Mar; 93(3):594-605. PubMed ID: 7512101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral norephedrine on common cold symptoms.
    Grønborg H; Winther B; Brofeldt S; Borum P; Mygind N
    Rhinology; 1983 Mar; 21(1):3-12. PubMed ID: 6344181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical beclomethasone on histamine-induced increases in nasal airflow resistance and secretion in perennial rhinitis.
    Studham JM; O'Connell F; Henderson J; Thomas VE; Fuller RW; Pride NB; Baraniuk JN
    Clin Otolaryngol Allied Sci; 1993 Aug; 18(4):285-90. PubMed ID: 8877187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a topical nasal decongestant in different formulations: the effect of viscosity.
    Johansson CJ; Carlson T; Olsson P; Bende M
    Acta Otolaryngol; 1992 Nov; 112(6):1032-7. PubMed ID: 1481657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenylpropanolamine on ostial and nasal airway resistance in healthy individuals.
    Melén I; Andréasson L; Ivarsson A; Jannert M; Johansson CJ
    Acta Otolaryngol; 1986; 102(1-2):99-105. PubMed ID: 3739696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs.
    Corrado OJ; Ollier S; Phillips MJ; Thomas JM; Davies RJ
    Br J Clin Pharmacol; 1987 Sep; 24(3):283-92. PubMed ID: 3117084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide and nasal histamine challenge.
    Pipkorn U
    Allergy; 1982 Jul; 37(5):359-63. PubMed ID: 7125153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K; Pipkorn U; Bake B; Blychert LO
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
    Graf P; Toll K; Palm J; Hallén H
    Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.
    Maniscalco M; Sofia M; Faraone S; Carratù L
    Allergy; 2000 Aug; 55(8):757-61. PubMed ID: 10955702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal provocation with histamine in allergic rhinitis patients: clinical significance and reproducibility.
    van Wijk RG; Mulder PG; Dieges PH
    Clin Exp Allergy; 1989 May; 19(3):293-8. PubMed ID: 2736430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge.
    Empey DW; Frosolono MF; Hughes DT; Perkins JG
    Br J Clin Pharmacol; 1984 Jul; 18(1):86-9. PubMed ID: 6204666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.
    Frossard N; Lacronique J; Melac M; Benabdesselam O; Braun JJ; Glasser N; Pauli G
    Allergy; 1997 Feb; 52(2):205-9. PubMed ID: 9105526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
    Lacroix JS; Mosimann BL
    J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects.
    Lacroix JS; Ricchetti AP; Morel D; Mossimann B; Waeber B; Grouzmann E
    Br J Pharmacol; 1996 Aug; 118(8):2079-84. PubMed ID: 8864546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.